IMMUNE RESPONSE TO HERPES SIMPLEX VIRUS IN PREGNANCY
妊娠期单纯疱疹病毒的免疫反应
基本信息
- 批准号:3081344
- 负责人:
- 金额:$ 6.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-08-01 至 1990-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pregnancy represents a partially immunocompromised state in
which infections caused by various pathogens such as herpes
simplex virus (HSV) are poorly tolerated. Aside from the direct
maternal morbidity encountered, HSV infections can be
transmitted to the fetus and newborn resulting in a high acute
perinatal mortality and long-term neurologic sequelae in
survivors. Natural killer cell cytotoxicity (NKC) and antibody-
dependent cellular cytotoxicity (ADCC) are primary
immunodefense systems which are thought to play a pivotal role
in HSV infection. The specific aims of this project set out to
define and characterize these immune responses in pregnancy.
Using an in vitro effector/target cell model, pregnant women's
mononuclear effector cells will be serially tested for NKC and
ADCC activity throughout gestation, specifically against HSV-
infected Chang liver target cells. Based on the applicant's
preliminary data which suggests an NKC deficient state in
pregnancy, a single cell agarose assay will be used to further
define this deficit in terms of its more basic functional
components, i.e., cellular adhesion, lysis, and recycling. Known
immunoregulatory agents will be tested in vitro for their ability
to reconstitute this pregnancy-associated NKC deficit.
Additionally, an investigation into the mechanism by which this
immunoregulation occurs will be undertaken by examining
cellular arachidonic acid lipoxygenation following pharmacologic
reconstitution. Achievement of these objectives will improve
our understanding of the immunology of HSV infection in
pregnancy and provide a more rational approach to the
prevention and control of this infectious and morbid process.
The goals outlined to this proposal are logistically obtainable and
would provide a starting point to begin my development as an
independent investigator in this field of study. My recent work
with Dr. Steve Kohl has provided me with a challenging research
focal point and the methodology to develop it. Both my
sponsors, and my department chairman, have given me clear
indications of their continued support in these endeavors. This
includes technical assistance, laboratory support, and adequate
freedom from other clinical responsibilities. As an institution,
The University of Texas Medical School is well recognized for its
academic achievements further emphasizing the richness of this
environment for a young investigator.
怀孕代表着部分免疫功能低下的状态
由疱疹等多种病原体引起的感染
单纯疱疹病毒(HSV)的耐受性很差。 除了直接
产妇发病时,HSV 感染可
传播给胎儿和新生儿,导致高度急性
围产期死亡率和长期神经系统后遗症
幸存者。 自然杀伤细胞的细胞毒性(NKC)和抗体-
依赖性细胞毒性(ADCC)是主要的
免疫防御系统被认为发挥着关键作用
在HSV感染中。 该项目的具体目标是
定义和表征怀孕期间的这些免疫反应。
使用体外效应器/靶细胞模型,孕妇
单核效应细胞将进行 NKC 和
ADCC 活性贯穿整个妊娠期,特别针对 HSV-
感染Chang肝脏靶细胞。 根据申请人的
初步数据表明 NKC 缺陷状态
怀孕时,单细胞琼脂糖测定将用于进一步
根据其更基本的功能来定义这种缺陷
成分,即细胞粘附、裂解和回收。 已知
免疫调节剂的能力将在体外进行测试
重建这种与妊娠相关的 NKC 缺陷。
此外,还对这一机制进行了调查
免疫调节的发生将通过检查来进行
药物作用后细胞花生四烯酸脂氧合
重构。 这些目标的实现将得到改善
我们对 HSV 感染免疫学的理解
怀孕并提供更合理的方法
预防和控制这种传染性和病态过程。
本提案概述的目标在逻辑上是可以实现的,并且
将为我的发展提供一个起点
该研究领域的独立研究者。 我最近的工作
与史蒂夫·科尔博士一起为我提供了一项具有挑战性的研究
焦点及其制定方法。 都是我的
赞助商和我的系主任已经给我明确的
表明他们对这些努力的持续支持。 这
包括技术援助、实验室支持和足够的
免于其他临床责任。 作为一个机构,
德克萨斯大学医学院以其
学术成就进一步强调了这一点的丰富性
一个年轻研究者的环境。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Immune modulation of natural killer cell cytotoxicity against herpes infected target cells in pregnancy.
自然杀伤细胞对妊娠期疱疹感染靶细胞的细胞毒性的免疫调节。
- DOI:10.1111/j.1600-0897.1990.tb01045.x
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Gonik,B;Loftin,KC;Tan,NS;Crump,J
- 通讯作者:Crump,J
Neonatal sex-steroid hormones and muscular strength of boys and girls in the first three years.
新生儿性类固醇激素和男孩和女孩头三年的肌肉力量。
- DOI:10.1002/dev.420170309
- 发表时间:1984
- 期刊:
- 影响因子:2.2
- 作者:Jacklin,CN;Maccoby,EE;Doering,CH;King,DR
- 通讯作者:King,DR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNARD GONIK其他文献
BERNARD GONIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNARD GONIK', 18)}}的其他基金
Co-Operative Multicenter Trials in Obstetrics & Maternal Fetal Medicine
产科合作多中心试验
- 批准号:
8903981 - 财政年份:1991
- 资助金额:
$ 6.31万 - 项目类别:
IMMUNE RESPONSE TO HERPES SIMPLEX VIRUS IN PREGNANCY
妊娠期单纯疱疹病毒的免疫反应
- 批准号:
3081343 - 财政年份:1987
- 资助金额:
$ 6.31万 - 项目类别:
IMMUNE RESPONSE TO HERPES SIMPLEX VIRUS IN PREGNANCY
妊娠期单纯疱疹病毒的免疫反应
- 批准号:
3081342 - 财政年份:1987
- 资助金额:
$ 6.31万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 6.31万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 6.31万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 6.31万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 6.31万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




